Celltrion is a leading global biopharmaceutical company dedicated to improving the health and well-being of patients.
We have presented a new paradigm to the global biologics market with the launch of the world’s first monoclonal antibody biosimilar.
Celltrion will continue to pursue its goal in promoting the health and well-being of patients.
